November 29, 2022
Mexican pharmaceutical company Genomma Lab Internacional said Sunday that it will promote Marco Sparvieri to CEO after a six-month transition period.
Sparvieri has been COO of Genomma Lab for four years. He joined the company in 2014 after 20 years a
Mexican pharmaceutical company says Marco Sparvieri will take the helm after a six-month transition period